Discounted Cash Flow
Orthopediatrics Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $37.3m | $-6.6m | $-5.5m | -17.6% | $-7.14 |
| 2017 | $45.6m (22.3%) | $-8.9m (-35.9%) | $-12.4m (-127.3%) | -19.6% (-11.1%) | $-5.86 (17.9%) |
| 2018 | $57.6m (26.2%) | $-12.0m (-34.6%) | $-20.8m (-67.7%) | -20.9% (-6.7%) | $-0.96 (83.6%) |
| 2019 | $72.6m (26.0%) | $-13.7m (-14.2%) | $-29.6m (-42.0%) | -18.9% (9.4%) | $-0.94 (2.1%) |
| 2020 | $71.1m (-2.0%) | $-32.9m (-139.9%) | $-29.0m (1.9%) | -46.3% (-144.9%) | $-1.82 (-93.6%) |
| 2021 | $98.0m (37.9%) | $-16.3m (50.6%) | $-21.2m (27.1%) | -16.6% (64.2%) | $-0.84 (53.8%) |
| 2022 | $122.3m (24.7%) | $1.3m (107.7%) | $1.3m (105.9%) | 1.0% (106.2%) | $0.06 (107.1%) |
| 2023 | $148.7m (21.6%) | $-21.0m (-1767.2%) | $-43.9m (-3591.6%) | -14.1% (-1470.8%) | $-0.92 (-1633.3%) |
| 2024 | $204.7m (37.6%) | $-37.8m (-80.3%) | $-41.3m (5.9%) | -18.5% (-31.0%) | $-1.64 (-78.3%) |
| 2025 | $236.3m (15.4%) | $-39.6m (-4.8%) | $-16.0m (61.4%) | -16.8% (9.2%) | $-1.69 (-3.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.